Design New Pyrano Quinoline Derivatives and Study of their Anti-Microbial Activity
Keywords:
Pyranoqunoline Reactions, benzo[h][1,6]Naphthyridines, Antimicrobial ActivityAbstract
4,5,7-Trichloro-3-(2-chloroethyl)-2-methylbenzo[h][1,6]naphthyridine 1 was selectively converted to 5-iminoether 5 by the reaction with sodium alkoxy in corresponding alcohol and to 2-methylbenzo[h][1,6]naphthyridin-5(6H)-one 2 by acetic acid reflux. The reaction selectively occurs at C5-position of the benzo[h][1,6]naphthyridine. Further, 2-methylbenzo[h][1,6] naphthayridin-5(6H)-one 2 furnish O and N alkylation products 3 and 4 with bromoethylacetate respectively. The reaction of 2 with bromoacetamide yield O-acetanilide i.e. 2-(4-chloro-12-methyl-16,17-dihydro-15-thia-6,11-diaza-cyclopenta[a]phenanthren-7-ylsulfanyl)-N-phenyl acetamide 6 in major amount.
References
- Roseman K. A.; Maribeth M. G.; Linfield, W. M. and Edwards Ben, E. J. Med. Chem.1969, 13, 230-233.
- Hinschberger, A.; Butt, s.; Lelong, V.; Boulouard, M.; Dumuis, A.; Dauphin, F.;Bureau, R.;?? Pfeiffer, B.; ??Renard P.; Rault, S. J. Med. Chem. 2003, 46, 138-147.
- Gorlitzer, K.; Bode, M.; Jones, P.G.; Jomaa, H.;? Wiesner, J. Pharmazie, 2007, 62, 15-26.
- Gorlitzer, K.; Bode, M.; Jones, P.G.; Jomaa, H. Pharmazie, 2005, 60, 172-174.
- Chrzastek, L.; Mianowska, B.; Sliwa, W. Aus, J. Chem. 1994, 47, 2129-2133.
- (a) Coatney, G. R. Survey of? Antimalarial Agents. Public Health Service Monograph
- No. 9; U. S. Government Printing Office: Washington DC. 1952; (b) Sliwa, W. Heterocycles
- 1979, 12, 1207-1237; c)? Matusiak, G.; Sliwa, W. Acta Chimica Hungarica. 1988, 125, 267-274.
- Martindale, R. J. The exta parmacopoeia. 30th ed.; Royal Pharm Soc Great Britain,Pharmaceutical: London, 1993; p 460.
- Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.;Saxena, P. R.; Humphrey, P. P. Pharmacol. Rev.? 1994, 46, 157-203.
- (a) Eglen, R. M.; Wong, E. H. F.; Dumuis, A.; Bockaert, J. Trends Pharmacol. Sci. 1995, 16,391-398; (b) Eglen, R. M.; Hegde, S. S. Exp. Opin. Invest. Drugs, 1996, 5, 373-388.
- Bureau, R.; Daveu, C.; Lemaitre, S.; Dauohin, F.; Landelle, H.; Lancelot, J. C.; Rault, S. J.Chem. Inf. Comput. Sci. 2002, 42, 962-967.
- Schaus, J. M.; Thompson, D. C.; Bloomquist, W. E.; Susemichel, A. D.; Calligaro, D. O.;Cohen, M. L. J. Med. Chem. 1998, 41, 19-1955.
- Curtet, S.; Soulier, J. L.; Zahradnick, I.; Giner, M.; Berque-Bestel, Fischmeister, R.;Langlois, M. J. Med. Chem. 2000, 43, 3761-3769.
- Lopez-Rodriguez, M. L.; Benhamu, B.; Viso, A.; Morcillo, M. J.; Murcia, M.; Orensanz, L.;Alfaro, M. J.; Martin, M. I. Bioorg. Med. Chem. 1999, 7, 2271-2281.
- Salama, H. M.; Labouta, I. A.; Moustafa M. A.; Moustafa. Alex. J. Pharm. Sci. 1990, 4, 44-46.
- Bonde, C. G.; Gaikwad, N. J. Bioorg. Med. Chem. 2004, 12, 2151-2161.
- Kucukguzel, S. G.; Oruc, E. E.;? Rollas, S.; Sahin, F.; Ozbek, A. Eur. J. Med. Chem. 2002,37, 197-206.
- Capan, G.; Ulusoy, N.; Ergenc, N.; Kiraz, M. Monatsh. Chem. 1999, 130, 1399-1407.
- Ergenc, N.; Capan, G. II Farmaco. 1994, 49, 133-135.
- Bhatt, J. J.; Shah, B. R.; Shah, H. P.; Trivedi, P. B.; Undavia, N. K.; Desai, N. C. Indian J.Chem. 1994, 33B, 189-192.
- Bukowski, L.; Janowiec, M.; Zwolska-Kwiek, Z.; Andrezejczyk, Z. Pharmazie 1998, 53,373-376.
- Barreca, M. L.; Chimirri, A.; Luca, L. D.; Monforte, A.; Monforte, P.; Rao, A.; Zappala, M.;
- Balzarini, J.; De Clercq, E.; Pannecouque, C.; Witvrouw, M. Bioorg. Med. Chem. Lett. 2001,11, 1793-1796.
- Andres, C. J.; Bronson, J. J.; Andrea, S. V. D.; Deshpande, M. S.; Falk, P. J.; Grant-Young,
- K.A.; Harte, W. E.; Ho, H. T.; Misco, P. F.; Robertson, J. G.; Stock, D.; Sun, Y.; Walsh, A.W. Bioorg. Med. Chem. Lett. 2000, 10, 715-717.
Downloads
Published
Issue
Section
License
Copyright (c) IJSRST
This work is licensed under a Creative Commons Attribution 4.0 International License.